• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives Azaspirodecane derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives

Introduction to 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine (CAS No. 1544376-10-4)

1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine, also known by its CAS number 1544376-10-4, is a unique compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of spirocyclic amines, which are characterized by their distinctive spirocyclic structure and potential biological activities. The spirocyclic framework of 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine provides a robust platform for the development of novel therapeutic agents, particularly in areas such as central nervous system (CNS) disorders and cancer.

The chemical structure of 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine consists of a spirocyclic ring system with two nitrogen atoms and two methyl groups attached to the nitrogen atoms at positions 1 and 8. This structural arrangement confers unique chemical and biological properties to the compound. Recent studies have highlighted the potential of spirocyclic amines in modulating various biological targets, including enzymes, receptors, and ion channels.

In the context of medicinal chemistry, 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine has been investigated for its potential as a lead compound in drug discovery. One of the key areas of interest is its activity as a modulator of G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane receptors that play crucial roles in cellular signaling pathways and are implicated in numerous diseases. Research has shown that 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine can selectively bind to specific GPCRs, thereby modulating their activity and potentially offering therapeutic benefits.

Beyond its potential as a GPCR modulator, 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine has also been explored for its anti-inflammatory properties. Inflammation is a complex biological response that is involved in various diseases, including autoimmune disorders and chronic conditions such as arthritis. Studies have demonstrated that 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine can inhibit the production of pro-inflammatory cytokines and reduce inflammation in vitro and in animal models. This makes it a promising candidate for the development of anti-inflammatory drugs.

The pharmacokinetic properties of 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine have also been studied to assess its suitability as a drug candidate. Pharmacokinetic parameters such as absorption, distribution, metabolism, excretion (ADME), and toxicity are critical factors in drug development. Preliminary studies have shown that 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine exhibits favorable ADME properties and low toxicity profiles in preclinical models. These findings suggest that it has the potential to be developed into a safe and effective therapeutic agent.

In addition to its therapeutic applications, 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine has been used as a tool compound in academic research to study the structure-function relationships of spirocyclic amines. Its unique chemical structure allows researchers to explore how subtle changes in the molecular architecture can affect biological activity and selectivity. This knowledge is valuable for the rational design of new compounds with improved pharmacological profiles.

The synthesis of 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine has been optimized using modern synthetic methods to ensure high yields and purity levels. Various synthetic routes have been reported in the literature, including multistep processes involving ring formation and functional group modifications. The ability to synthesize this compound efficiently is crucial for its further development and commercialization.

In conclusion, 1,8-Dimethyl-1,8-diazaspiro[4.5]decan-4-amine (CAS No. 1544376-10-4) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique spirocyclic structure and favorable biological properties make it an attractive candidate for the development of novel therapeutic agents targeting GPCRs and inflammation-related disorders. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)